|
業務類別
|
Biotechnology |
|
業務概覽
|
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States. |
| 公司地址
| 389 Interpace Parkway, Suite 450, Parsippany, NJ, USA, 07054 |
| 電話號碼
| +1 908 517-9500 |
| 傳真號碼
| +1 908 375-8272 |
| 公司網頁
| https://www.cormedix.com |
| 員工數量
| 191 |
| Mr. Joseph Todisco |
Chairman of the Board and Chief Executive Officer |
美元 684.35K |
08/01/2026 |
| Mr. Michael Seckler |
Executive Vice President and Chief Commercial Officer |
-- |
08/01/2026 |
| Ms. Beth Zelnick Kaufman |
Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary |
美元 497.60K |
29/04/2026 |
| Ms. Susan Blum |
Executive Vice President, Chief Financial Officer and Principal Accounting Officer |
-- |
29/04/2026 |
| Ms. Elizabeth Hurlburt |
Executive Vice President and Chief Operating Officer |
美元 479.64K |
29/04/2026 |
|
|
| Ms. Janet M. Dillione |
Independent Director |
29/04/2026 |
| Mr. Robert A. Stewart |
Independent Director |
29/04/2026 |
| Mr. Gregory Duncan |
Independent Director |
29/04/2026 |
| Mr. Joseph Todisco |
Chairman of the Board and Chief Executive Officer |
08/01/2026 |
| Mr. Steven W. Lefkowitz |
Independent Director |
29/04/2026 |
| Dr. Alan W. Dunton,M.D. |
Independent Director |
29/04/2026 |
| Mr. Myron Kaplan |
Lead Independent Director |
08/01/2026 |
|
|
|
|
